SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18799100
Source:
http://linkedlifedata.com/resource/pubmed/id/18799100
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003873
,
umls-concept:C0017262
,
umls-concept:C0039099
,
umls-concept:C0054946
,
umls-concept:C0087111
,
umls-concept:C0185117
,
umls-concept:C0205216
,
umls-concept:C0393022
,
umls-concept:C0439230
,
umls-concept:C1417326
,
umls-concept:C1706319
,
umls-concept:C2911684
pubmed:issue
4
pubmed:dateCreated
2008-9-18
pubmed:abstractText
To characterise the effects of rituximab on synovial tissue of patients with refractory rheumatoid arthritis (RA).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8308521
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD20
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors
,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed-author:BresnihanBB
,
pubmed-author:FearonUU
,
pubmed-author:FitzGeraldOO
,
pubmed-author:VealeD JDJ
,
pubmed-author:WalshC A ECA
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
656-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18799100-Antibodies, Monoclonal
,
pubmed-meshheading:18799100-Antibodies, Monoclonal, Murine-Derived
,
pubmed-meshheading:18799100-Antigens, CD20
,
pubmed-meshheading:18799100-Arthritis, Rheumatoid
,
pubmed-meshheading:18799100-B-Lymphocytes
,
pubmed-meshheading:18799100-Cohort Studies
,
pubmed-meshheading:18799100-Female
,
pubmed-meshheading:18799100-Humans
,
pubmed-meshheading:18799100-Immunologic Factors
,
pubmed-meshheading:18799100-Knee Joint
,
pubmed-meshheading:18799100-Male
,
pubmed-meshheading:18799100-Middle Aged
,
pubmed-meshheading:18799100-Synovial Membrane
pubmed:articleTitle
Decreased CD20 expression in rheumatoid arthritis synovium following 8 weeks of rituximab therapy.
pubmed:affiliation
Deptartment of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland. cearawalsh@eircom.net
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't